Sanofi Pauses Recruitment in All Phase 3 Trials of Tolebrutinib
Sanofi has decided to pause recruitment globally in its Phase 3 clinical trials of tolebrutinib, an experimental BTK inhibitor,…
Articles by Vanda Pinto, PhD
Moderna COVID-19 Vaccine Seen as Safe and Effective With MG
The Moderna COVID-19 vaccine was safe and did not particularly worsen clinical symptoms in people with myasthenia gravis (MG),…
COVID-19 Infection Can Prolong Hospital Stays for MG Patients in US
COVID-19 infection prolongs the length of hospital stay by nearly twofold for patients with myasthenia gravis (MG), according to…
Gender, Race, and Thymectomy Increase Risk for Lupus in MG
People with myasthenia gravis (MG) have an increased risk of developing systemic lupus erythematosus or SLE, another type…
Rare Case of MG and Bone Marrow Disorders Reported
An extremely rare case of myasthenia gravis (MG) associated with paroxysmal nocturnal hemoglobinuria (PNH) and aplastic anemia (AA), two…
Bladder Problems Common in MG, Particularly for Late-onset Patients
Bladder problems like urinary incontinence, urgency, and nocturia — waking up frequently to urinate — are common in people with…
Older Late-onset Patients Have Overall Positive Prognosis
Patients who start experiencing symptoms of myasthenia gravis (MG) after age 65 have an overall good prognosis and response…
Worse Post-surgery Prognosis for MG Patients With Other Diseases
People with generalized myasthenia gravis (MG) who have other diseases, or comorbidities, have a worse prognosis and are less…
Poor Lung Function, Steroid Use Tied to Risk of Severe COVID-19
Poor lung function and disease management, along with previous long-term use of corticosteroids, older age, and the presence of cancer…
Study: MG Patients Not at Increased Risk for Atrial Fibrillation
People with myasthenia gravis (MG) are not at a higher risk of developing atrial fibrillation, a potentially serious heart…